Pityriasis rubra pilaris (PRP) is an idiopathic, papulosquamous inflammatory dermatosis. It is
characterized by hyperkeratotic follicular papules coalescing into orange-red scaly plaques …

Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease that affects men and women
of all ages and also children. The clinical appearance of PRP is highly variable, as is the …

Pityriasis rubra pilaris (PRP) ist eine seltene papulosquamöse Erkrankung. Die Behandlung
ist schwierig; das therapeutische Arsenal umfasst topische Corticosteroide, Phototherapie …

Pityriasis rubra pilaris (PRP) is a rare inflammatory papulosquamous skin disease that is
often refractory to conventional therapies. The off-label use of biologics, such as anti–tumor …

Background Treatment response for psoriasis is typically evaluated using clinical scores.
However, patients can relapse after clinical clearance, suggesting persistent inflammation …

The clinical manifestations of PP and PRP are less well known to rheumatologists than
those of psoriasis, and recent advances in our insight on their pathogenesis may eventually …

Background Pityriasis rubra pilaris (PRP) is an uncommon papulosquamous inflammatory
disease of the skin, which may progress to erythroderma. The diagnosis is based on both …

Ustekinumab is approved for the treatment of psoriasis and Crohn's disease. Because many
dermatological conditions are due to immune-mediated development, ustekinumab may be …

Ionizing radiation was used in the past for treatment of several benign cutaneous conditions,
and particularly hemangiomas. Even though radiotherapy was generally effective, it …

Pityriasis rubra pilaris (PRP) is a rare, inflammatory papulosquamous skin disease with
unknown exact etiology. Historically, PRP has been challenging to diagnose, especially …